UNSPSC 51284904: Methenamine/potassium phosphate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM550. This VA Drug Class (AM550) classifies this compound as belonging to the group METHENAMINE SALTS ANTIMICROBIALS.

UNSPSC 51284904 Methenamine/potassium phosphate is a Commodity code that nominally designates a specific pharmaceutical ingredient, but recent state and local opportunities posted under this code show substantial mismatch between the code's chemical name and actual procurement activity. The recent opportunities instead span medical and first aid supplies, naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, and direct-to-manufacturer prescription programs. Issuing bodies include Florida counties (Seminole County), Texas state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and regional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The code appears to be applied inconsistently or as a catch-all default for pharmaceutical and medical supply procurements that do not map cleanly to single-ingredient codes.

Recent activity concentrates in Florida, Texas, and Minnesota, with the most concrete procurement signals emerging from the City of Tampa's sealed-bid IFB for medical and first aid supplies to the Tampa Fire Department Rescue Division—169 line items with an estimated contract value of $700,000.00, due March 13, 2026, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802) on January 20, 2026, with a response deadline of March 26, 2026, for generic multi-source pharmaceuticals and OTC products, distributed through authorized wholesalers and effective July 1, 2026. Seminole County, Florida solicited 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually via IFB 60459723LAS with a deadline of July 26, 2023 (note: date appears inconsistent with the June 30, 2026, posting date). The Texas HHS Commission issued an exploratory RFI (HHS0017013) in March 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs, signaling potential future formal procurement.